Laura A Williams sold $490k of ARDX
Chief Patient Officer at ARDELYX, INC.. 80,000 shares at an average of $6.12, traded Aug 26, 2025, filed Aug 28, 2025.
Score components
- +15RoleOfficer
- +18Trade size$490k at market
- +5Share of holdings soldSold 18% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-041339, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 26, 2025 | MOption exercise Common Stock10b5-1 | +50,000 | $0.99 | $50k | 446,322 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Common Stock10b5-1 | -50,000 | $6.12 | $306k | 396,322 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Common Stock10b5-1 | -30,000 | $6.12 | $184k | 366,322 | Aug 28, 2025 |
| Aug 26, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 112,000 | Aug 28, 2025 |
Related signals
Other insiders at ARDELYX, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 3Weak | ARDELYX, INC. | Michael Raab President & CEO | $243k 41,666 shares | -2% | |
| 18Weak | ARDELYX, INC. | Michael Raab President & CEO | $261k 41,666 shares | -2% | |
| 37Weak | ARDELYX, INC. | Eric Duane Foster Chief Commercial Officer | $61k 10,439 shares | -2% | |
| 53Moderate | ARDELYX, INC. | Michael Raab President & CEO | $269k 45,982 shares | -2% | |
| 37Weak | ARDELYX, INC. | Mike Kelliher See Remarks | $56k 9,595 shares | -3% | |
| 30Weak | ARDELYX, INC. | James Parker Brady Chief Human Resources Officer | $15k 2,543 shares | -1% | |
| 37Weak | ARDELYX, INC. | Susan Hohenleitner Chief Financial Officer | $12k 2,033 shares | -1% | |
| 37Weak | ARDELYX, INC. | Laura A Williams See Remarks | $48k 8,176 shares | -2% | |
| 35Weak | ARDELYX, INC. | Joseph James Reilly See Remarks | $29k 4,991 shares | -3% | |
| 30Weak | ARDELYX, INC. | John E Bishop See Remarks | $19k 3,179 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.